# Soluble Activin Receptor Type IIB Improves Muscle Regeneration Following Crotalus atrox Venom-Induced Damage

**Authors:** Medha Sonavane, Ali Alqallaf, Robert D. Mitchell, José R. Almeida, Soheil Gilabadi, Nicholas J. Richards, Sodiq Adeyemi, Jarred Williams, Olli Ritvos, Sakthivel Vaiyapuri, Ketan Patel

PMC · DOI: 10.3390/toxins17020059 · Toxins · 2025-01-28

## TL;DR

This study shows that using a soluble activin receptor can help repair muscle damage caused by snake venom and reduce fibrosis.

## Contribution

The study demonstrates a novel therapeutic approach using soluble activin receptor type IIb to improve muscle regeneration after venom-induced damage.

## Key findings

- Soluble activin receptor type IIb treatment increased the size of regenerating muscle fibers.
- The treatment reduced fibrotic tissue levels in venom-damaged muscle.

## Abstract

Viper bite envenoming often results in prominent skeletal muscle damage. According to our previous studies, the prolonged presence of Crotalus atrox venom toxins induced extensive muscle damage, which mimicked the outcome of chronic muscle damage often seen in human muscular dystrophies. In the case of chronic muscle damage, two critical processes occur: muscle regeneration is impaired, and fibrosis develops. Myostatin/activin signalling is a key regulator of both of these processes. Myostatin and its closely related molecules, in particular activin, inhibit the proliferation and differentiation of myocytes while promoting proliferation of fibroblasts and expression of extracellular matrix proteins. Thus, attenuating myostatin/activin signalling offers an attractive means of promoting muscle development while decreasing fibrosis. Hence, we have used the soluble activin receptor type IIb, which acts as a ligand trap for both myostatin and activin, to dampen signalling and assessed whether this intervention could alter the pathological trajectory of C. atrox venom-induced muscle damage in mice. We report that the soluble activin receptor type IIb treatment increased the size of regenerating fibres while reducing the level of fibrotic tissues in venom-damaged muscle.

## Linked entities

- **Proteins:** LOC5521725 (growth/differentiation factor 8), Actbeta (Activin-beta)
- **Species:** Crotalus atrox (taxon 8730), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** MSTN (myostatin) [NCBI Gene 2660] {aka GDF8, MSLHP}, INHBE (inhibin subunit beta E) [NCBI Gene 83729]
- **Diseases:** fibrosis (MESH:D005355), muscle damage (MESH:D009133), muscular dystrophies (MESH:D009136)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11861606/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11861606/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC11861606/full.md

---
Source: https://tomesphere.com/paper/PMC11861606